DIAGNOS Inc.
Toronto Stock Exchange VenturesTotal Valuation
DIAGNOS Inc. carries a market capitalization of 26.99M, placing it among publicly traded companies globally. Its enterprise value stands at 28.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 26.99M |
| Enterprise Value | 28.95M |
Share Statistics
DIAGNOS Inc. currently has 120.41M shares outstanding.
| Shares Outstanding | 120.41M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 450.12, and the price-to-book ratio stands at -2.99.
| PE Ratio | N/A |
| PS Ratio | 450.12 |
| PB Ratio | -2.99 |
| P/TBV Ratio | 42.91 |
| P/FCF Ratio | -7.88 |
| P/OCF Ratio | -7.85 |
Enterprise Valuation
| EV / Sales | 442.10 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
DIAGNOS Inc. maintains a current ratio of 1.49, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 204.05, indicating elevated leverage, while an interest coverage ratio of -10.55 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.49 |
| Quick Ratio | 1.44 |
| Debt / Equity | 204.05 |
| Debt / EBITDA | -0.34 |
| Interest Coverage | -10.55 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -151.17 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
DIAGNOS Inc.'s stock has gained approximately 29.26829% over the past 52 weeks. The 50-day moving average sits at 0.22, while the 200-day moving average is 0.29.
| Beta (5Y) | N/A |
| 52-Week Price Change | 29.26829% |
| 50-Day Moving Average | 0.22 |
| 200-Day Moving Average | 0.29 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, DIAGNOS Inc. generated 65,478.00 in revenue and converted that into -4.56M in net income, yielding earnings per share of -0.04. EBITDA reached -4.10M, while operating income came in at -4.23M.
| Revenue | 65,478.00 |
| Gross Profit | 10,014.00 |
| Operating Income | -4.23M |
| Pretax Income | -4.56M |
| Net Income | -4.56M |
| EBITDA | -4.10M |
| EBIT | -4.23M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
DIAGNOS Inc. holds 1.93M in cash and equivalents against 1.40M in total debt, resulting in a net debt position of 901,219.00. Total book value stands at -9.86M, with working capital of 722,233.00 providing operational flexibility.
| Cash & Cash Equivalents | 1.93M |
| Total Debt | 1.40M |
| Net Debt | 901,219.00 |
| Equity (Book Value) | -9.86M |
| Book Value Per Share | -0.09 |
| Working Capital | 722,233.00 |
Cash Flow
DIAGNOS Inc. produced -3.75M in operating cash flow over the past twelve months. After subtracting -11,061.00 in capital expenditures, free cash flow totaled -3.76M - equivalent to -0.04 per share.
| Operating Cash Flow | -3.75M |
| Capital Expenditures | -11,061.00 |
| Free Cash Flow | -3.76M |
| FCF Per Share | -0.04 |
Margins
DIAGNOS Inc. operates with a gross margin of 15.29, reflecting its pricing power and cost economics. The operating margin of -6,459.65 and net profit margin of -6,956.84 provide insight into operational efficiency.
| Gross Margin | 15.29 |
| Operating Margin | -6,459.65 |
| Pretax Margin | -6,956.84 |
| Profit Margin | -6,956.84 |
| EBITDA Margin | -6,261.93 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -8.18 |
| FCF Yield | -12.70 |
Stock Splits
DIAGNOS Inc.'s most recent stock split took place on April 24, 2019 with a 10:1 split ratio.
| Last Split Date | 4/24/2019 |
| Split Ratio | 10:1 |
Scores
DIAGNOS Inc. posts an Altman Z-Score of -29.91, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -29.91 |